Veloxis Pharmaceuticals Announces Initiation of STRATO Study of LCP-Tacro(TM ... MarketWatch (press release) The STRATO study is designed to explore whether a conversion of patients who have symptomatic tremor from treatment with standard immediate release twice-daily tacrolimus capsules to extended release once-daily LCP-Tacro(TM) tablets leads to a ... |
